0.017291 0.000000 0.000000 0.000000 0.017291 0.000000 0.000000 0.000000 0.018234 0.00000 0.00000 0.00000 Brzozowski, A.M. Jiracek, J. Zakova, L. Antolikova, E. Watson, C.J. Turkenburg, J.P. Dodson, G.G. http://mmcif.pdb.org/dictionaries/ascii/mmcif_pdbx.dic 16 90.00 90.00 90.00 57.832 57.832 54.842 C3 H7 N O2 89.093 y ALANINE L-peptide linking C6 H15 N4 O2 1 175.209 y ARGININE L-peptide linking C4 H8 N2 O3 132.118 y ASPARAGINE L-peptide linking C3 H7 N O2 S 121.158 y CYSTEINE L-peptide linking C5 H10 N2 O3 146.144 y GLUTAMINE L-peptide linking C5 H9 N O4 147.129 y GLUTAMIC ACID L-peptide linking C2 H5 N O2 75.067 y GLYCINE peptide linking C6 H10 N3 O2 1 156.162 y HISTIDINE L-peptide linking H2 O 18.015 WATER non-polymer C6 H13 N O2 131.173 y ISOLEUCINE L-peptide linking C6 H13 N O2 131.173 y LEUCINE L-peptide linking C9 H11 N O2 165.189 y PHENYLALANINE L-peptide linking C5 H9 N O2 115.130 y PROLINE L-peptide linking C3 H7 N O3 105.093 y SERINE L-peptide linking C4 H9 N O3 119.119 y THREONINE L-peptide linking C9 H11 N O3 181.189 y TYROSINE L-peptide linking C5 H11 N O2 117.146 y VALINE L-peptide linking N 1 N N N 2 S C N 3 N C N 4 N O N 5 N C N 6 N O N 7 N H N 8 N H N 9 N H N 10 N H N 11 N H N 12 N H N 13 N H N 14 N N N 15 S C N 16 N C N 17 N O N 18 N C N 19 N C N 20 N C N 21 N N N 22 N C N 23 N N N 24 N N N 25 N O N 26 N H N 27 N H N 28 N H N 29 N H N 30 N H N 31 N H N 32 N H N 33 N H N 34 N H N 35 N H N 36 N H N 37 N H N 38 N H N 39 N H N 40 N H N 41 N N N 42 S C N 43 N C N 44 N O N 45 N C N 46 N C N 47 N O N 48 N N N 49 N O N 50 N H N 51 N H N 52 N H N 53 N H N 54 N H N 55 N H N 56 N H N 57 N H N 58 N N N 59 R C N 60 N C N 61 N O N 62 N C N 63 N S N 64 N O N 65 N H N 66 N H N 67 N H N 68 N H N 69 N H N 70 N H N 71 N H N 72 N N N 73 S C N 74 N C N 75 N O N 76 N C N 77 N C N 78 N C N 79 N O N 80 N N N 81 N O N 82 N H N 83 N H N 84 N H N 85 N H N 86 N H N 87 N H N 88 N H N 89 N H N 90 N H N 91 N H N 92 N N N 93 S C N 94 N C N 95 N O N 96 N C N 97 N C N 98 N C N 99 N O N 100 N O N 101 N O N 102 N H N 103 N H N 104 N H N 105 N H N 106 N H N 107 N H N 108 N H N 109 N H N 110 N H N 111 N N N 112 N C N 113 N C N 114 N O N 115 N O N 116 N H N 117 N H N 118 N H N 119 N H N 120 N H N 121 N N N 122 S C N 123 N C N 124 N O N 125 N C Y 126 N C Y 127 N N Y 128 N C Y 129 N C Y 130 N N N 131 N O N 132 N H N 133 N H N 134 N H N 135 N H N 136 N H N 137 N H N 138 N H N 139 N H N 140 N H N 141 N H N 142 N O N 143 N H N 144 N H N 145 N N N 146 S C N 147 N C N 148 N O N 149 S C N 150 N C N 151 N C N 152 N C N 153 N O N 154 N H N 155 N H N 156 N H N 157 N H N 158 N H N 159 N H N 160 N H N 161 N H N 162 N H N 163 N H N 164 N H N 165 N H N 166 N H N 167 N N N 168 S C N 169 N C N 170 N O N 171 N C N 172 N C N 173 N C N 174 N C N 175 N O N 176 N H N 177 N H N 178 N H N 179 N H N 180 N H N 181 N H N 182 N H N 183 N H N 184 N H N 185 N H N 186 N H N 187 N H N 188 N H N 189 N N N 190 S C N 191 N C N 192 N O N 193 N C Y 194 N C Y 195 N C Y 196 N C Y 197 N C Y 198 N C Y 199 N C N 200 N O N 201 N H N 202 N H N 203 N H N 204 N H N 205 N H N 206 N H N 207 N H N 208 N H N 209 N H N 210 N H N 211 N H N 212 N N N 213 S C N 214 N C N 215 N O N 216 N C N 217 N C N 218 N C N 219 N O N 220 N H N 221 N H N 222 N H N 223 N H N 224 N H N 225 N H N 226 N H N 227 N H N 228 N H N 229 N N N 230 S C N 231 N C N 232 N O N 233 N C N 234 N O N 235 N O N 236 N H N 237 N H N 238 N H N 239 N H N 240 N H N 241 N H N 242 N H N 243 N N N 244 S C N 245 N C N 246 N O N 247 R C N 248 N O N 249 N C N 250 N O N 251 N H N 252 N H N 253 N H N 254 N H N 255 N H N 256 N H N 257 N H N 258 N H N 259 N H N 260 N N N 261 S C N 262 N C N 263 N O N 264 N C Y 265 N C Y 266 N C Y 267 N C Y 268 N C Y 269 N C Y 270 N C N 271 N O N 272 N O N 273 N H N 274 N H N 275 N H N 276 N H N 277 N H N 278 N H N 279 N H N 280 N H N 281 N H N 282 N H N 283 N H N 284 N N N 285 S C N 286 N C N 287 N O N 288 N C N 289 N C N 290 N C N 291 N O N 292 N H N 293 N H N 294 N H N 295 N H N 296 N H N 297 N H N 298 N H N 299 N H N 300 N H N 301 N H N 302 N H N 1 N sing N 2 N sing N 3 N sing N 4 N sing N 5 N sing N 6 N sing N 7 N doub N 8 N sing N 9 N sing N 10 N sing N 11 N sing N 12 N sing N 13 N sing N 14 N sing N 15 N sing N 16 N sing N 17 N sing N 18 N sing N 19 N doub N 20 N sing N 21 N sing N 22 N sing N 23 N sing N 24 N sing N 25 N sing N 26 N sing N 27 N sing N 28 N sing N 29 N sing N 30 N sing N 31 N sing N 32 N sing N 33 N doub N 34 N sing N 35 N sing N 36 N sing N 37 N sing N 38 N sing N 39 N sing N 40 N sing N 41 N sing N 42 N sing N 43 N sing N 44 N sing N 45 N doub N 46 N sing N 47 N sing N 48 N sing N 49 N sing N 50 N doub N 51 N sing N 52 N sing N 53 N sing N 54 N sing N 55 N sing N 56 N sing N 57 N sing N 58 N sing N 59 N sing N 60 N sing N 61 N doub N 62 N sing N 63 N sing N 64 N sing N 65 N sing N 66 N sing N 67 N sing N 68 N sing N 69 N sing N 70 N sing N 71 N sing N 72 N sing N 73 N sing N 74 N doub N 75 N sing N 76 N sing N 77 N sing N 78 N sing N 79 N sing N 80 N sing N 81 N sing N 82 N doub N 83 N sing N 84 N sing N 85 N sing N 86 N sing N 87 N sing N 88 N sing N 89 N sing N 90 N sing N 91 N sing N 92 N sing N 93 N doub N 94 N sing N 95 N sing N 96 N sing N 97 N sing N 98 N sing N 99 N sing N 100 N sing N 101 N doub N 102 N sing N 103 N sing N 104 N sing N 105 N sing N 106 N sing N 107 N sing N 108 N sing N 109 N sing N 110 N sing N 111 N doub N 112 N sing N 113 N sing N 114 N sing N 115 N sing N 116 N sing N 117 N sing N 118 N sing N 119 N sing N 120 N doub N 121 N sing N 122 N sing N 123 N sing N 124 N sing Y 125 N sing Y 126 N doub Y 127 N doub N 128 N sing Y 129 N sing N 130 N sing Y 131 N sing N 132 N sing N 133 N sing N 134 N sing N 135 N sing N 136 N sing N 137 N sing N 138 N sing N 139 N sing N 140 N sing N 141 N sing N 142 N sing N 143 N doub N 144 N sing N 145 N sing N 146 N sing N 147 N sing N 148 N sing N 149 N sing N 150 N sing N 151 N sing N 152 N sing N 153 N sing N 154 N sing N 155 N sing N 156 N sing N 157 N sing N 158 N sing N 159 N sing N 160 N sing N 161 N sing N 162 N sing N 163 N sing N 164 N doub N 165 N sing N 166 N sing N 167 N sing N 168 N sing N 169 N sing N 170 N sing N 171 N sing N 172 N sing N 173 N sing N 174 N sing N 175 N sing N 176 N sing N 177 N sing N 178 N sing N 179 N sing N 180 N sing N 181 N sing N 182 N sing N 183 N sing N 184 N sing N 185 N doub N 186 N sing N 187 N sing N 188 N sing N 189 N sing Y 190 N doub Y 191 N sing Y 192 N sing N 193 N sing Y 194 N doub N 195 N sing Y 196 N doub N 197 N sing Y 198 N sing N 199 N sing N 200 N sing N 201 N sing N 202 N sing N 203 N sing N 204 N sing N 205 N sing N 206 N sing N 207 N sing N 208 N doub N 209 N sing N 210 N sing N 211 N sing N 212 N sing N 213 N sing N 214 N sing N 215 N sing N 216 N sing N 217 N sing N 218 N sing N 219 N sing N 220 N sing N 221 N sing N 222 N sing N 223 N sing N 224 N sing N 225 N doub N 226 N sing N 227 N sing N 228 N sing N 229 N sing N 230 N sing N 231 N sing N 232 N sing N 233 N sing N 234 N sing N 235 N sing N 236 N sing N 237 N sing N 238 N doub N 239 N sing N 240 N sing N 241 N sing N 242 N sing N 243 N sing N 244 N sing N 245 N sing N 246 N sing N 247 N sing N 248 N sing N 249 N sing N 250 N sing N 251 N sing N 252 N sing N 253 N sing N 254 N doub N 255 N sing N 256 N sing N 257 N sing N 258 N sing Y 259 N doub Y 260 N sing Y 261 N sing N 262 N sing Y 263 N doub N 264 N sing Y 265 N doub N 266 N sing Y 267 N sing N 268 N sing N 269 N sing N 270 N sing N 271 N sing N 272 N sing N 273 N sing N 274 N sing N 275 N sing N 276 N sing N 277 N sing N 278 N doub N 279 N sing N 280 N sing N 281 N sing N 282 N sing N 283 N sing N 284 N sing N 285 N sing N 286 N sing N 287 N sing N 288 N sing N 289 N sing US Proc.Natl.Acad.Sci.USA PNASA6 0040 0027-8424 107 1966 10.1073/PNAS.0911785107 20133841 Implications for the Active Form of Human Insulin Based on the Structural Convergence of Highly Active Hormone Analogues. 2010 10.2210/pdb2ws4/pdb pdb_00002ws4 1.000000 0.000000 0.000000 0.000000 1.000000 0.000000 0.000000 0.000000 1.000000 0.00000 0.00000 0.00000 100 1 CCD 2009-02-20 ADSC CCD SINGLE WAVELENGTH M x-ray 1 0.976 1.0 ID14-4 ESRF 0.976 SYNCHROTRON ESRF BEAMLINE ID14-4 2383.698 INSULIN A CHAIN 1 syn polymer B27-B30 DELETION 2939.392 INSULIN B CHAIN RESIDUES 25-50 YES 1 syn polymer 18.015 water 24 nat water no no GIVEQCCTSICSLYQLENYCN GIVEQCCTSICSLYQLENYCN A polypeptide(L) no no FVNQHLCGSHLVEALYLVCGERGFFP FVNQHLCGSHLVEALYLVCGERGFFP B polypeptide(L) n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n 1 2.3 47 NONE 3.0 0.055M NA2SO4 PH 3.0 chem_comp_atom chem_comp_bond database_2 pdbx_database_status pdbx_initial_refinement_model repository Initial release Database references Derived calculations Refinement description Version format compliance Data collection Database references Other Refinement description 1 0 2010-02-09 1 1 2012-04-04 1 2 2023-12-20 _database_2.pdbx_DOI _database_2.pdbx_database_accession _pdbx_database_status.status_code_sf INSULIN (HUMAN) MUTANT WITH PHE B 24 REPLACED BY GLY (F24G) (NMR, REPRESENTATIVE PLUS 8 STRUCTURES) NMR STRUCTURE OF HUMAN INSULIN MUTANT GLY- B8-SER, HIS-B10-ASP PRO-B28-LYS, LYS- B29-PRO, 20 STRUCTURES INSULINE(1SEC) AND UV LASER EXCITED FLUORESCENCE INSULIN (T3R3) (PH 6.4, 0.75 M NACL) COMPLEXED WITH TWO ZINC IONS AND TYLENOL ( 4'-HYDROXYACETANILIDE) INSULINE(60SEC) AND UV LASER EXCITED FLUORESCENCE NMR STRUCTURE OF HUMAN INSULIN MUTANT HIS- B10-ASP, VAL-B12-ALA, PRO-B28-LYS, LYS- B29-PRO, 15 STRUCTURES R6 HUMAN INSULIN HEXAMER (SYMMETRIC), NMR, 10 STRUCTURES CRYSTAL STRUCTURE OF DESTRIPEPTIDE (B28-B30) INSULIN STRUCTURE OF INSULIN T6 HUMAN INSULIN AT 1.0 A RESOLUTION CRYSTALLOGRAPHIC AND SOLUTION STUDIES OF N- LITHOCHOLYL INSULIN: A NEW GENERATION OF PROLONGED-ACTING INSULINS. FIRST PROTEIN STRUCTURE DETERMINED FROM X- RAY POWDERDIFFRACTION DATA INSULIN (T3R3) (PH 5.6, 1.0 M NACL) COMPLEXED WITH TWO ZINC IONS AND TYLENOL ( 4'-HYDROXYACETANILIDE) INSULIN MUTANT (B1, B10, B16, B27)GLU, DES -B30, NMR, 25 STRUCTURES CRYSTAL STRUCTURE FORM ULTALENTE INSULIN MICROCRYSTALS HUMAN INSULIN TWO DISULFIDE MODEL, NMR, 10 STRUCTURES NMR STRUCTURE OF HUMAN INSULIN MUTANT HIS- B10-ASP, VAL-B12-ABA, PRO-B28-LYS, LYS- B29-PRO, 15 STRUCTURES NMR STRUCTURE OF THE HUMAN INSULIN-HIS(B16 ) DESPENTAPEPTIDE INSULIN IN ACETIC ACID (PH 2 ) HUMAN INSULIN HEXAMERS WITH CHAIN B HIS MUTATED TO TYR MOL_ID: 1; MOLECULE: INSULIN; CHAIN: A, B; ENGINEERED: YES MUTATION: DES-[PHE(B 25)]; FIRST PROTEIN STRUCTURE DETERMINED FROM X- RAY POWDERDIFFRACTION DATA MINI-PROINSULIN, TWO CHAIN INSULIN ANALOG MUTANT: DES B30, HIS(B 10)ASP, PRO(B 28)ASP, NMR, 20 STRUCTURES HUMAN INSULIN HEXAMERS WITH CHAIN B HIS MUTATED TO TYR COMPLEXED WITH PHENOL INSULIN MUTANT A3 GLY,(B1, B10, B16, B27) GLU, DES-B30, NMR, 19 STRUCTURES CRYSTAL STRUCTURE FORM ULTALENTE INSULIN MICROCRYSTALS INSULIN MUTANT A8 HIS,(B1, B10, B16, B27) GLU, DES-B30, NMR, 26 STRUCTURES INSULIN (T3R3) COMPLEX WITH TWO ZINC IONS THE STRUCTURE OF THE RESORCINOL/INSULIN R6 HEXAMER STRUCTURE OF THE RHOMBOHEDRAL FORM OF THE M-CRESOL/INSULIN R6 HEXAMER ENHANCING THE ACTIVITY OF INSULIN AT RECEPTOR EDGE: CRYSTALSTRUCTURE AND PHOTO- CROSS-LINKING OF A8 ANALOGUES DEHYDRATED T6 HUMAN INSULIN AT 295 K INSULIN AT PH 2: STRUCTURAL ANALYSIS OF THE CONDITIONS PROMOTING INSULIN FIBRE FORMATION. R6 HUMAN INSULIN HEXAMER (NON-SYMMETRIC), NMR, 10 STRUCTURES NMR STRUCTURE OF HUMAN INSULIN UNDER AMYLOIDOGENICCONDITION, 15 STRUCTURES SOLUTION STRUCTURE OF THE MONOMERIC [THR(B27 )->PRO,PRO(B28)->THR] INSULIN MUTANT (PT INSULIN) NON-STANDARD DESIGN OF UNSTABLE INSULIN ANALOGUES WITHENHANCED ACTIVITY STRUCTURE OF B28 ASP INSULIN IN COMPLEX WITH PHENOL DEHYDRATED T6 HUMAN INSULIN AT 100 K HUMAN INSULIN DISULFIDE ISOMER, NMR, 10 STRUCTURES SOLUTION STRUCTURE OF HUMAN PROINSULIN C- PEPTIDE HUMAN INSULIN HEXAMERS WITH CHAIN B HIS MUTATED TO TYR COMPLEXED WITH RESORCINOL 1.3 A STRUCTURE OF T3R3 HUMAN INSULIN AT 100 K CRYSTAL STRUCTURE OF HUMAN INSULIN-DEGRADING ENZYME IN COMPLEX WITH INSULIN R6 HUMAN INSULIN HEXAMER (SYMMETRIC), NMR, 20 STRUCTURES STRUCTURE OF THE MONOCLINIC FORM OF THE M -CRESOL/INSULIN R6 HEXAMER CRYSTAL STRUCTURE OF ALLO-ILEA2-INSULIN, AN INACTIVE CHIRALANALOGUE: IMPLICATIONS FOR THE MECHANISM OF RECEPTOR NMR STRUCTURE OF HUMAN INSULIN MUTANT GLY- B8-D-SER, HIS-B10-ASP PRO-B28-LYS, LYS -B29-PRO, 20 STRUCTURES NMR STRUCTURE OF HUMAN INSULIN MUTANT HIS- B5-ALA, HIS-B10-ASP PRO-B28-LYS, LYS- B29-PRO, 20 STRUCTURES R6 HUMAN INSULIN HEXAMER (SYMMETRIC), NMR, ' GREEN' SUBSTATE, AVERAGE STRUCTURE CRYSTAL STRUCTURE OF AN UNSTABLE INSULIN ANALOG WITH NATIVEACTIVITY. NMR STRUCTURE OF HUMAN INSULIN MUTANT ILE- A2-ALA, HIS-B10-ASP, PRO-B28-LYS, LYS- B29-PRO, 15 STRUCTURES MOL_ID: 1; MOLECULE: INSULIN; CHAIN: A, B; ENGINEERED: YES MUTATION: S(B 9)D; CRYSTAL STRUCTURE OF HUMAN INSULIN DEGRADING ENZYME IN COMPLEX WITH IODINATED INSULIN NMR STRUCTURE OF HUMAN INSULIN IN 20% ACETIC ACID, ZINC-FREE, 10 STRUCTURES NMR STRUCTURE OF HUMAN INSULIN MUTANT ILE- A2-ALLO-ILE, HIS-B10-ASP, PRO-B28-LYS, LYS-B29-PRO, 15 STRUCTURES DIABETES-ASSOCIATED MUTATIONS IN HUMAN INSULIN : CRYSTALSTRUCTURE AND PHOTO-CROSS-LINKING STUDIES OF A-CHAINVARIANT INSULIN WAKAYAMA R6 HUMAN INSULIN HEXAMER (SYMMETRIC), NMR, ' RED' SUBSTATE, AVERAGE STRUCTURE 1.2 A STRUCTURE OF T3R3 HUMAN INSULIN AT 100 K INSULIN, MONOCLINIC CRYSTAL FORM STRUCTURE OF INSULIN INSULIN (HUMAN, DES-PENTAPEPTIDE (B 26 - B 30)) (NMR, REPRESENTATIVE PLUS 14 STRUCTURES) HUMAN INSULIN MUTANT SERB9GLU R6 HUMAN INSULIN HEXAMER (SYMMETRIC), NMR, REFINED AVERAGE STRUCTURE STRUCTURAL PROPERTIES OF THE B25TYR-NME- B26PHE INSULIN MUTANT. INSULIN (HUMAN) MUTANT WITH PHE B 24 REPLACED BY SER (F24S) (NMR, REPRESENTATIVE PLUS 9 STRUCTURES) LYS(B28)PRO(B29)-HUMAN INSULIN AN ACTIVE MINI-PROINSULIN, M2PI NMR STRUCTURE OF HUMAN INSULIN MUTANT HIS- B10-ASP, VAL-B12-THR, PRO-B28-LYS, LYS- B29-PRO, 15 STRUCTURES INSULIN MUTANT B16 GLU, B24 GLY, DES-B30 , NMR, 20 STRUCTURES INSULIN COMPLEXED WITH 4-HYDROXYBENZAMIDE NMR STRUCTURE OF HUMAN INSULIN MUTANT ILE- A2-GLY, VAL-A3-GLY, HIS-B10-ASP, PRO- B28-LYS, LYS-B29-PRO, 20 STRUCTURES SEMI-SYNTHETIC ANALOGUE OF HUMAN INSULIN PROB26-DTI SEMI-SYNTHETIC ANALOGUE OF HUMAN INSULIN NMEALAB26-INSULIN AT PH 7.5 SEMI-SYNTHETIC ANALOGUE OF HUMAN INSULIN PROB26-DTI IN MONOMER FORM SEMI-SYNTHETIC ANALOGUE OF HUMAN INSULIN NMETYRB26-INSULIN IN MONOMER FORM SEMI-SYNTHETIC ANALOGUE OF HUMAN INSULIN NMETYRB26-INSULIN IN HEXAMER FORM SEMI-SYNTHETIC ANALOGUE OF HUMAN INSULIN NMEALAB26-INSULIN AT PH 3.0 SEMI-SYNTHETIC HIGHLY ACTIVE ANALOGUE OF HUMAN INSULIN D-PROB26-DTI-NH2 SEMI-SYNTHETIC HIGHLY ACTIVE ANALOGUE OF HUMAN INSULIN NMEALAB26-DTI-NH2 SEMI-SYNTHETIC HIGHLY ACTIVE ANALOGUE OF HUMAN INSULIN NMEHISB26-DTI-NH2 PDBE Y PDBE 2009-09-03 REL REL HOH water 9606 HUMAN HOMO SAPIENS sample 9606 HUMAN HOMO SAPIENS sample ENGINEERED RESIDUE IN CHAIN B, TYR 50 TO PRO B27-B30 RESIDUES ARE DELETED 1MSO PDB ENTRY 1MSO PDB experimental model HOH 2001 3 HOH HOH 2001 A HOH 2002 3 HOH HOH 2002 A HOH 2003 3 HOH HOH 2003 A HOH 2004 3 HOH HOH 2004 A HOH 2005 3 HOH HOH 2005 A HOH 2006 3 HOH HOH 2006 A HOH 2007 3 HOH HOH 2007 A HOH 2008 3 HOH HOH 2008 A HOH 2009 3 HOH HOH 2009 A HOH 2010 3 HOH HOH 2010 A HOH 2011 3 HOH HOH 2011 A HOH 2012 3 HOH HOH 2012 A HOH 2013 3 HOH HOH 2013 A HOH 2001 3 HOH HOH 2001 B HOH 2002 3 HOH HOH 2002 B HOH 2003 3 HOH HOH 2003 B HOH 2004 3 HOH HOH 2004 B HOH 2005 3 HOH HOH 2005 B HOH 2006 3 HOH HOH 2006 B HOH 2007 3 HOH HOH 2007 B HOH 2008 3 HOH HOH 2008 B HOH 2009 3 HOH HOH 2009 B HOH 2010 3 HOH HOH 2010 B HOH 2011 3 HOH HOH 2011 B GLY 1 n 1 GLY 1 A ILE 2 n 2 ILE 2 A VAL 3 n 3 VAL 3 A GLU 4 n 4 GLU 4 A GLN 5 n 5 GLN 5 A CYS 6 n 6 CYS 6 A CYS 7 n 7 CYS 7 A THR 8 n 8 THR 8 A SER 9 n 9 SER 9 A ILE 10 n 10 ILE 10 A CYS 11 n 11 CYS 11 A SER 12 n 12 SER 12 A LEU 13 n 13 LEU 13 A TYR 14 n 14 TYR 14 A GLN 15 n 15 GLN 15 A LEU 16 n 16 LEU 16 A GLU 17 n 17 GLU 17 A ASN 18 n 18 ASN 18 A TYR 19 n 19 TYR 19 A CYS 20 n 20 CYS 20 A ASN 21 n 21 ASN 21 A n 1 1 B VAL 2 n 2 VAL 2 B ASN 3 n 3 ASN 3 B GLN 4 n 4 GLN 4 B HIS 5 n 5 HIS 5 B LEU 6 n 6 LEU 6 B CYS 7 n 7 CYS 7 B GLY 8 n 8 GLY 8 B SER 9 n 9 SER 9 B HIS 10 n 10 HIS 10 B LEU 11 n 11 LEU 11 B VAL 12 n 12 VAL 12 B GLU 13 n 13 GLU 13 B ALA 14 n 14 ALA 14 B LEU 15 n 15 LEU 15 B TYR 16 n 16 TYR 16 B LEU 17 n 17 LEU 17 B VAL 18 n 18 VAL 18 B CYS 19 n 19 CYS 19 B GLY 20 n 20 GLY 20 B GLU 21 n 21 GLU 21 B ARG 22 n 22 ARG 22 B GLY 23 n 23 GLY 23 B PHE 24 n 24 PHE 24 B PHE 25 n 25 PHE 25 B PRO 26 n 26 PRO 26 B 4.9835 -0.4820 1.6267 4.3855 0.0874 4.8392 -0.0491 -0.0063 0.1108 -0.1537 0.0741 0.0756 -0.1054 0.0775 -0.0249 0.0375 -0.0157 0.0121 0.0073 -0.0061 0.0136 refined -10.3010 -8.4753 -10.8770 X-RAY DIFFRACTION A 1 A 21 X-RAY DIFFRACTION 1 B 2 B 26 X-RAY DIFFRACTION 1 author_and_software_defined_assembly PISA 4 tetrameric 3760 -41.2 5560 1.0000000000 0.0000000000 0.0000000000 0.0000000000 1.0000000000 0.0000000000 0.0000000000 0.0000000000 1.0000000000 1_555 x,y,z identity operation 0.0000000000 0.0000000000 0.0000000000 0.0000000000 -1.0000000000 0.0000000000 -1.0000000000 0.0000000000 0.0000000000 0.0000000000 0.0000000000 -1.0000000000 16_444 -y-1/2,-x-1/2,-z-1/2 crystal symmetry operation -28.9160000000 -28.9160000000 -27.4210000000 1 A CG GLN 5 A CG GLN 5 0 Y 1 A CD GLN 5 A CD GLN 5 0 Y 1 A OE1 GLN 5 A OE1 GLN 5 0 Y 1 A NE2 GLN 5 A NE2 GLN 5 0 Y 1 B CA VAL 18 A B CA VAL 18 0 Y 1 B CB VAL 18 A B CB VAL 18 0 Y 1 B CG1 VAL 18 A B CG1 VAL 18 0 Y 1 B CG2 VAL 18 A B CG2 VAL 18 0 Y 1 B CB GLU 21 B CB GLU 21 0 Y 1 B CG GLU 21 B CG GLU 21 0 Y 1 B CD GLU 21 B CD GLU 21 0 Y 1 B OE1 GLU 21 B OE1 GLU 21 0 Y 1 B OE2 GLU 21 B OE2 GLU 21 0 Y 1 B CG ARG 22 B CG ARG 22 0 Y 1 B CD ARG 22 B CD ARG 22 0 Y 1 B NE ARG 22 B NE ARG 22 0 Y 1 B CZ ARG 22 B CZ ARG 22 0 Y 1 B NH1 ARG 22 B NH1 ARG 22 0 Y 1 B NH2 ARG 22 B NH2 ARG 22 0 Y 1 B PHE 1 B PHE 1 1 Y 1 A A CYS ASN 20 21 136.75 1 21.60 2.20 113.40 135.00 A A A CA CB CG GLN GLN GLN 5 5 5 N 1 6.77 1.10 114.20 120.97 A A A CA CB SG CYS CYS CYS 20 20 20 N 1 A A CG CD GLU GLU 4 4 0.110 0.015 1.515 1.625 N 1 A A CB CG GLN GLN 5 5 -0.330 0.027 1.521 1.191 N 20.943 -2.02 0.00 0.00 -2.02 0.00 4.03 0.948 0.907 HYDROGENS HAVE BEEN ADDED IN THE RIDING POSITIONS. U VALUES RESIDUAL. ONLY OCCUPANCY OF SIDE CHAINS A5,B18,B21,B22 ARE SET TO ZERO DUE TO THEIR HIGH MOBILITY. B1 IS NOT MODELLED AS IT IS FULLY DISORDERED 0.27816 0.22215 0.22448 1.90 20.00 170 3704 4.4 99.67 9.726 0.121 RANDOM 1 THROUGHOUT MOLECULAR REPLACEMENT 0.432 0.170 0.80 0.80 1.40 PDB ENTRY 1MSO MAXIMUM LIKELIHOOD MASK 1.90 20.00 24 383 0 0 359 0.024 0.021 356 2.272 1.961 485 9.789 5.000 44 38.249 25.333 15 16.796 15.000 50 0.131 0.200 54 0.009 0.020 274 1.416 1.500 229 2.414 2.000 362 3.681 3.000 127 5.705 4.500 123 2.234 3.000 356 8.327 3.000 24 3.632 3.000 347 0.459 0.295 1.949 15 253 20 98.17 23.0 1.75 27.00 2WS4 4948 0.0 0.09 1 8.50 7.8 97.5 0.70 1.75 1.78 3.50 1 5.5 80.1 refinement REFMAC 5.5.0082 data reduction DENZO data scaling SCALEPACK phasing MOLREP Semi-synthetic analogue of human insulin ProB26-DTI in monomer form 1 N N 2 N N 3 N N 3 N N A ILE 2 A ILE 2 HELX_P A CYS 7 A CYS 7 1 1 6 A SER 12 A SER 12 HELX_P A ASN 18 A ASN 18 1 2 7 B SER 9 B SER 9 HELX_P B CYS 19 B CYS 19 1 3 11 disulf 2.064 A CYS 6 A SG CYS 6 1_555 A CYS 11 A SG CYS 11 1_555 disulf 2.053 A CYS 7 A SG CYS 7 1_555 B CYS 7 B SG CYS 7 1_555 disulf 1.999 A CYS 20 A SG CYS 20 1_555 B CYS 19 B SG CYS 19 1_555 HORMONE INSULIN, CARBOHYDRATE METABOLISM, GLUCOSE METABOLISM, HORMONE, ANALOGUE, DIABETES MELLITUS INS_HUMAN UNP 1 P01308 INS_HUMAN UNP 2 P01308 90 110 2WS4 1 21 P01308 A 1 1 21 25 50 2WS4 1 26 P01308 B 2 1 26 2 TYR engineered mutation PRO 26 2WS4 B P01308 UNP 50 26 97 I 4 2 2